Elastase-dependent congenital neutropenia

Abstract

Congenital neutropenia, which refers to an inherited deficiency in neutrophils, is a rare pathologic condition that affects approximately 0.0001-0.0009% of the general population. While congenital neutropenia can result from mutations in approximately 30 genes, its leading cause is gain-of-function mutations in the ELANE gene, which encodes the neutrophil granule serine protease, neutrophil elastase. This review focuses on established and novel concepts in the genetic, molecular and cellular mechanisms underlying neutrophil elastase-dependent neutropenia, and discusses possible new avenues for neutropenia research as well as potential novel treatment options that target pathogenic elastase variants.

Keywords

Neutropenia / neutrophil elastase / ELANE gene editing / neutrophil elastase inhibitor / secretory leukocyte protease inhibitor

References

[1] Horwitz MS,Grimes HL.ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.Hematol Oncol Clin North Am2013;27:19-41, vii PMCID:PMC3559001

[2] Klein C.Congenital neutropenia.Hematology Am Soc Hematol Educ Program2009;:344-50

[3] Skokowa J,Touw IP,Welte K.Severe congenital neutropenias.Nat Rev Dis Primers2017;3:17032 PMCID:PMC5821468

[4] Donadieu J,Beaupain B,Chantelot CB.Congenital neutropenia: diagnosis, molecular bases and patient management.Orphanet J Rare Dis2011;6:26 PMCID:PMC3127744

[5] Touw IP.Congenital neutropenia: disease models guiding new treatment strategies.Curr Opin Hematol2022;29:27-33 PMCID:PMC8654271

[6] Papadaki HA,Almeida A.Congenital and acquired chronic neutropenias: challenges, perspectives and implementation of the EuNet-INNOCHRON action.Hemasphere2020;4:e406 PMCID:PMC7306309

[7] Hernandez PA,Lukens JN.Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.Nat Genet2003;34:70-4

[8] Skokowa J.Circumventing mutation to nix neutropenia.N Engl J Med2021;384:1956-8

[9] Vilboux T,Malicdan MC.A congenital neutrophil defect syndrome associated with mutations in VPS45.N Engl J Med2013;369:54-65 PMCID:PMC3787600

[10] Mir P,Findik B.New insights into the pathomechanism of cyclic neutropenia.Ann N Y Acad Sci2020;1466:83-92

[11] Dale DC,Shannon JA.Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.Blood Adv2022;6:3861-9 PMCID:PMC9278291

[12] Rosenberg PS,Bolyard AA.Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.Br J Haematol2010;150:196-9 PMCID:PMC2906693

[13] Benson KF,Person RE.Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase.Nat Genet2003;35:90-6

[14] Majewski P,Grygier B,Osiecka O.Inhibitors of serine proteases in regulating the production and function of neutrophil extracellular traps.Front Immunol2016;7:261 PMCID:PMC4928128

[15] Papayannopoulos V,Hakkim A.Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps.J Cell Biol2010;191:677-91 PMCID:PMC3003309

[16] Skrzeczynska-Moncznik J,Osiecka O.Differences in staining for neutrophil elastase and its controlling inhibitor SLPI reveal heterogeneity among neutrophils in psoriasis.J Invest Dermatol2020;140:1371-1378.e3

[17] Zabieglo K,Majchrzak-Gorecka M.The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.J Leukoc Biol2015;98:99-106 PMCID:PMC4467168

[18] Nasri M,Mir P.CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.Haematologica2020;105:598-609 PMCID:PMC7049355

[19] Horwitz MS.Neutrophil elastase: nonsense lost in translation.Cell Stem Cell2021;28:790-2

[20] Nanua S,Xia J.Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.Blood2011;117:3539-47 PMCID:PMC3072877

[21] Rao S,Soares de Brito J.Dissecting ELANE neutropenia pathogenicity by human HSC gene editing.Cell Stem Cell2021;28:833-845.e5 PMCID:PMC8106646

[22] Garg B,Wang B,Horwitz MS.Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response.J Biol Chem2020;295:7492-500 PMCID:PMC7247317

[23] Li FQ.Characterization of mutant neutrophil elastase in severe congenital neutropenia.J Biol Chem2001;276:14230-41

[24] Grenda DS,Ghatak J.Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.Blood2007;110:4179-87 PMCID:PMC2234798

[25] Nustede R,Klimenkova O.ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.Br J Haematol2016;172:219-27

[26] Olofsen PA,Roovers O.PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.Blood Adv2021;5:775-86 PMCID:PMC7876869

[27] Tidwell T,Nayak RC.Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms.Blood2014;123:562-9 PMCID:PMC3901069

[28] Köllner I,Schreek S.Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response.Blood2006;108:493-500

[29] Liu Q,Shu Z,Tang XM.Two paternal mosaicism of mutation in ELANE causing severe congenital neutropenia exhibit normal neutrophil morphology and ROS production.Clin Immunol2019;203:53-8

[30] Nayak RC,Aronow BJ.Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells.J Clin Invest2015;125:3103-16 PMCID:PMC4563755

[31] Massullo P,Bunnell BA.Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes.Blood2005;105:3397-404 PMCID:PMC1895019

[32] Makaryan V,Fletcher B,Aprikyan AA.Elastase inhibitors as potential therapies for ELANE-associated neutropenia.J Leukoc Biol2017;102:1143-51 PMCID:PMC5597518

[33] du Bois RM,Paakko P,Takahashi H.Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin.Blood1991;77:2724-30

[34] Sallenave JM,Cox G,Gauldie J.Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils.J Leukoc Biol1997;61:695-702

[35] Allaeys I,Bourgoin SG.Human inflammatory neutrophils express genes encoding peptidase inhibitors: production of elafin mediated by NF-κB and CCAAT/enhancer-binding protein β.J Immunol2021;206:1943-56

[36] Badola S,Robison K.Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data.Genomics2006;88:173-84

[37] Klimenkova O,Klimiankou M.A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.Blood2014;123:1239-49

[38] Dannenmann B,Mir P.Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34⁺ cells preceding leukemic transformation.Exp Hematol2019;71:51-60

[39] Qiu Y,Hu N.A Truncated granulocyte colony-stimulating factor receptor (g-csfr) inhibits apoptosis induced by neutrophil elastase G185R mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.J Biol Chem2017;292:3496-505 PMCID:PMC5336180